Tilus, Mercilyn G.

HRN: 03-96-19  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2024
CO-AMOXICLAV 625MG (TAB)
01/11/2024
01/17/2024
PO
625mgtqb
Q8
Cap Lr
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: